IL0011651580 - Common Stock
PAINREFORM LTD
NASDAQ:PRFX (11/20/2024, 8:00:00 PM)
After market: 0.96 -0.08 (-7.69%)1.04
-0.36 (-25.71%)
PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
PAINREFORM LTD
65 Yigal Alon St.
TEL AVIV-YAFO 6745442
P: 97237177051
CEO: Ilan Hadar
Employees: 6
Website: https://painreform.com/
These stocks are moving in today's session
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Gap analysis on 2024-11-20: gap up and gap down stocks in today's session.
Stay updated with the stocks that are on the move in Wednesday's pre-market session.
TEL AVIV, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Here you can normally see the latest stock twits on PRFX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: